Accelerate Diagnostics Inc (AXDX) Inventory Turnover Ratio, from fourth quarter 2024 to fourth quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Accelerate Diagnostics Inc   (NASDAQ: AXDX)
 

Accelerate Diagnostics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Accelerate Diagnostics Inc 's inventory turnover ratio, the ratio that measures Accelerate Diagnostics Inc 's ability to manage its supply chain, sequentially decreased to 2.6 in the fourth quarter 2024, but it does not raise any concerns as Accelerate Diagnostics Inc continue to execute well, and the inventory turnover ratio remains above the average. Accelerate Diagnostics Inc 's average inventory processing period in the Dec 31 2024 quarter, has increased to 140 days, from 139 days, in the Sep 30 2024 quarter.

Within Healthcare sector 166 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 895 in the third quarter 2024, to 1121.

AXDX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Accelerate Diagnostics Inc Market Share?

What is Inventory Turnover Ratio?




AXDX Inventory Turnover Ratio (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Inventory Growth -13.84 % -16.18 % -36.88 % -38.35 % -36.27 %
Y / Y Cost of Sales Growth -16.46 % 100 % 0 % 11.05 % 12.34 %
Inventory Turnover Ratio (TTM) 2.6 2.63 2.22 1.94 1.67
AXDX's Total Ranking # 1121 # 895 # 837 # 1123 # 1290
Average inventory processing period 140 139 165 188 219
Seq. Inventory Growth -4.23 % -7.6 % -0.8 % -1.84 % -6.84 %
Seq. Cost of Sales Growth 0 % 0 % 0 % -16.46 % 139.4 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 8
Healthcare Sector # 167
Overall Market # 1121

Inventory Turnover Ratio Statistics
High Average Low
2.63 1.19 0.21
(Sep 30 2024)   (Dec 31 2017)




Financial Statements
Accelerate Diagnostics Inc 's Inventories $ 3 Millions Visit AXDX's Balance sheet
Accelerate Diagnostics Inc 's Cost of Revenues TTM $ 8 Millions Visit AXDX's Income Statement
What are AXDX's Sales? Visit AXDX's Sales by Segment

Other Inventory Turnover Ratios
Accelerate Diagnostics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AXDX's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AXDX's Competitors
Inventory Turnover Ratio for AXDX's Suppliers
Inventory Turnover Ratio for AXDX's Customers

You may also want to know
AXDX's Sales Growth Rates AXDX's Pe Price to earnings ratio AXDX's Receivables Turnover Ratio AXDX's Stock Quote
AXDX's Net Income Growth Rates AXDX's Ps Price to Sales ratio AXDX's Sales per Employee AXDX's Asset Turnover Ratio
AXDX's Net Margin AXDX's Pb Price to Book ratio AXDX's Financial Strength Ratios AXDX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2024 Inventories at quarter ending Dec 31 2024
Collegium Pharmaceutical Inc   7.61 $ 252.661  Millions$ 33  Millions
Inogen Inc   7.48 $ 180.964  Millions$ 24  Millions
Nutriband Inc   7.23 $ 1.396  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.17 $ 11.314  Millions$ 2  Millions
Cardiff Lexington Corporation  7.11 $ 3.842  Millions$ 1  Millions
Kewaunee Scientific Corporation  7.10 $ 160.000  Millions$ 23  Millions
Carlisle Companies Incorporated  7.08 $ 3,115.900  Millions$ 440  Millions
Twist Bioscience Corporation  6.87 $ 182.962  Millions$ 27  Millions
Scorpius Holdings inc   6.76 $ 3.196  Millions$ 0  Millions
Hims and Hers Health Inc   6.59 $ 303.000  Millions$ 46  Millions
Dih Holding Us Inc   6.52 $ 56.000  Millions$ 9  Millions
Fonar Corporation  6.51 $ 18.440  Millions$ 3  Millions
Evolus Inc   6.46 $ 83.970  Millions$ 13  Millions
Warby Parker Inc   6.40 $ 344.000  Millions$ 54  Millions
Earth Science Tech Inc   6.31 $ 2.055  Millions$ 0  Millions
Patterson Companies Inc   6.19 $ 5,179.000  Millions$ 836  Millions
23andme Holding Co  6.18 $ 98.000  Millions$ 16  Millions
Adaptive Biotechnologies Corporation  6.15 $ 72.080  Millions$ 12  Millions
Charles River Laboratories International inc   6.12 $ 2,026.863  Millions$ 331  Millions
Bionexus Gene Lab Corp   6.00 $ 7.335  Millions$ 1  Millions
Scilex Holding Company  5.86 $ 16.689  Millions$ 3  Millions
Avantor Inc   5.78 $ 4,504.300  Millions$ 779  Millions
Veracyte Inc   5.72 $ 114.000  Millions$ 20  Millions
Exact Sciences Corporation  5.60 $ 776.850  Millions$ 139  Millions
Cryoport inc   5.44 $ 128.754  Millions$ 24  Millions
Strata Skin Sciences Inc  5.40 $ 14.000  Millions$ 3  Millions
Medinotec Inc   5.12 $ 5.063  Millions$ 1  Millions
Henry Schein Inc   5.01 $ 8,657.000  Millions$ 1,727  Millions
Integer Holdings Corporation  4.80 $ 1,257.000  Millions$ 262  Millions
Harrow Inc   4.79 $ 49.245  Millions$ 10  Millions

Date modified: 2026-06-22T14:32:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.